Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia and Thyringia, Germany

Recruiting

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00022088
• Lead Sponsor: niversitätsfrauenklinik Erlangen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-06-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 2650

Inclusion Criteria

Age >= 18 yrs;
Written informed consent;
Pregnant women or members of the hospital care team in the department of obstetrics

Exclusion Criteria

lack of ability to provide written informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of seropositive pregnant women in pregnancy in three cohorts (1st month, 2nd month, 3rd month)

Secondary Outcome Measures

Name	Time	Method
Time of SARS-CoV-2-Infection of mother and fetus/newborn<br>Complications in pregnancy<br>Mode and complications of delivery<br>Neonatal complications<br>Rate of seropositive members of the hospital care team in the department of obstetrics